Embleema comes out of stealth to connect patients, life sciences, and regulators through its healthcare blockchain-enabled personal health record (PHR) platform.
Embleema, a NYC-based patient-focused healthcare blockchain network, today emerged from stealth after one year of R&D, to launch the public beta release of its patient-driven, HIPAA-compliant, blockchain-enabled personal health records (PHR) platform. The new blockchain-driven PHR platform give patients complete control over their medical data – and disrupt the $127 Billion Drug Development Market and $200 Billion digital health market – by directly connecting patients, life sciences, and regulators.